Susi, a Negative Regulator of Drosophila PI3-Kinase  by Wittwer, Franz et al.
Developmental Cell, Vol. 8, 817–827, June, 2005, Copyright ©2005 by Elsevier Inc. DOI 10.1016/j.devcel.2005.04.002
Susi, a Negative Regulator
of Drosophila PI3-KinaseFranz Wittwer,1 Malika Jaquenoud,2 Walter Brogiolo,1
Marcel Zarske,1 Philipp Wüstemann,1,3
Rafael Fernandez,4 Hugo Stocker,1
Matthias P. Wymann,2 and Ernst Hafen1,*
1Zoologisches Institut
Universität Zürich
Winterthurerstr. 190
CH-8057 Zürich
Switzerland
2 Institute of Biochemistry and Genetics
Center of Biomedicine
Department Clinical and Biological Sciences
University of Basel
Mattenstrasse 28
CH-4058 Basel
Switzerland
3The Genetics Company, Inc.
Wagistrasse 27
8952 Zürich-Schlieren
Switzerland
4Novartis Institute for Biomedical Research, Inc.
Functional Genomics
100 Technology Square, Room 6216
Cambridge, Massachusetts 02139
Summary
The Phosphatidylinositol-3 kinase/Protein Kinase B
(PI3K/PKB) signaling pathway controls growth, me-
tabolism, and lifespan in animals, and deregulation of
its activity is associated with diabetes and cancer in
humans. Here, we describe Susi, a coiled-coil domain
protein that acts as a negative regulator of insulin sig-
naling in Drosophila. Whereas loss of Susi function
increases body size, overexpression of Susi reduces
growth. We provide genetic evidence that Susi nega-
tively regulates dPI3K activity. Susi directly binds to
dP60, the regulatory subunit of dPI3K. Since Susi has
no overt similarity to known inhibitors of PI3K/PKB
signaling, it defines a novel mechanism by which this
signaling cascade is kept in check. The fact that Susi
is expressed in a circadian rhythm, with highest
levels during the night, suggests that Susi attenuates
insulin signaling during the fasting period.
Introduction
PI3K/PKB signaling regulates growth and metabolism
in mammals and Drosophila. In mammals, PI3K/PKB
signaling is activated by the insulin-like growth factor
receptor (IGFR) and by the insulin receptor (IR) (Nakae
et al., 2001; Yenush and White, 1997). Signaling in re-
sponse to IGFR activation is required for cell growth
and proliferation during development. The same cas-
cade is activated by IR to regulate glucose levels in the
blood in mammals. In Drosophila, the functions of IR*Correspondence: hafen@zool.unizh.chand IGFR are fulfilled by a single prototypical receptor,
the Drosophila insulin receptor (dINR). As in mammals,
dINR regulates cell growth and metabolism (Stocker
and Hafen, 2000).
The mechanisms of insulin receptor signaling are
similar in mammals and Drosophila (Lizcano and Alessi,
2002; Stocker and Hafen, 2000). The activated receptor
phosphorylates insulin receptor substrate proteins (IRS
1–4 or dIRS/Chico), thereby creating binding sites for
SH2-domain-containing proteins including the regula-
tory subunit of class IA phosphoinositide 3-kinase
(class IA PI3K, hereafter called PI3K). PI3K is a lipid
kinase consisting of the regulatory subunit P85 (dP60
in Drosophila) and the catalytic subunit P110 (dP110 in
Drosophila). By binding to IRS, PI3K is recruited to the
membrane where it phosphorylates the 3# position of
phosphatidylinositol-(4,5)-bisphosphate (PIP2) and
thereby generates phosphatidylinositol-(3,4,5)-tris-
phosphate (PIP3). Elevated levels of PIP3 recruit the PH-
domain-containing protein kinase B (PKB/AKT) to the
plasma membrane and permit its further activation by
phosphoinositide-dependent kinase 1 (PDK1). PKB
transmits the signal by the inhibition of transcription
factors of the FOXO (forkhead box, subgroup “O”) fam-
ily and by phosphorylation of other downstream tar-
gets.
The activity of PI3K/PKB signaling needs to be ad-
justed continuously to the developmental and meta-
bolic state of the organism. Therefore, the activity of
most positively acting signaling components is held in
check by negative regulators. Several mechanisms of
how PI3K/PKB signaling is regulated at the level of
PI3K are known in mammals. First, the level of PIP3,
the product of PI3K activity, is negatively regulated by
two lipid phosphatases that dephosphorylate PIP3.
Whereas PTEN (the phosphatase and tensin homolog
on chromosome 10) dephosphorylates PIP3 at the 3#
position (Di Cristofano and Pandolfi, 2000), SHIP (SH2-
domain-containing inositol 5# phosphatase) dephos-
phorylates PIP3 at the 5# position (Rohrschneider et al.,
2000). PI3K activity is also modulated directly by the
levels of its adaptor P85. Under conditions where the
molar ratio of P85/P110 is increased, P85 monomers
compete with P85/P110 heterodimers for binding to
phosphorylated YxxM motifs on IRS (Kodaki et al.,
1994; Rodriguez-Viciana et al., 1997). Similarly, overex-
pression of the dP60 subunit of Drosophila PI3K also
exerts a dominant-negative effect (Britton et al., 2002;
Weinkove et al., 1999). Furthermore, activity of mam-
malian PI3K is regulated by Ruk, a protein containing
two SH3 domains, a proline-rich motif, and a coiled-
coiled domain. Ruk binds to the SH3 domain of the reg-
ulatory subunit of PI3K, inhibits its activity, and induces
apoptosis when overexpressed in cultured cells (Gout
et al., 2000). Its role as negative regulator of insulin/IGF
signaling in an animal model has not been described
yet.
Here we describe Susi, a novel negative regulator of
insulin signaling in Drosophila. Gain-of-function muta-
tions of Susi were identified in a genetic screen for
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Soverexpressed. Loss-of-function alleles of Susi showed
that it encodes a negative regulator of insulin signaling f
aand that Susi protein acts by inhibiting dPI3K activity.
Susi encodes a coiled-coiled domain protein that in- m
eteracts with the dP60 regulatory subunit of dPI3K.
t
(Results
e
1Overexpression of Susi Suppresses
ddINR-Induced Overgrowth
dTo identify negative regulators of dINR signaling, we
ccarried out a misexpression screen for genes that sup-
epress the overgrowth phenotype caused by overex-
spression of wild-type dINR in the developing eye using
the UAS/Gal4 system (Figures 1A–1C). We tested 5,400
ofly lines containing random insertions of an enhancer-
Spromoter (EP) element that permits the transcription of
Wgenes flanking the insertion in response to Gal4. Sev-
teral independent lines that strongly suppressed the
wdINR-induced eye phenotype (among them EP(7-66);
TFigures 1D and 2A) contained EP insertions upstream
tof the first coding exon of the B4 gene (Sotillos et al.,
h1997). The suppression is caused by the overexpres-
ssion of the B4 gene, since overexpression of B4 from
ca UAS transgene had the same effect. Therefore, we
prenamed the B4 locus Suppressor of signaling by insu-
lin (Susi).
tSusi encodes a novel protein with a predicted coiled-
lcoil (CC) domain (amino acids 916–942 according to the
upredicted amino acid sequence CG9239-PA, GenBank
eaccession number NP 477325). Proteins that are obvi-
lous orthologs of Susi exist in other insect species such
tas Drosophila pseudoobscura (75% identical amino
aacids, see Experimental Procedures) and Anopheles
hgambiae (GenBank accession number EAA12152). Ow-
Ping to the low sequence conservation and the large size
of the family of CC domain-containing proteins, we
were unable to resolve whether one of the CC domain L
proteins from higher organisms is a Susi ortholog. O
Susi overexpression suppresses dINR function in o
other developmental processes also. For example, em- t
bryonic lethality associated with the expression of dINR i
by en-Gal4 was suppressed by the concomitant ex- o
pression of Susi. Importantly, the effects of Susi overex- i
pression appear to be specific for dINR/dPI3K signal- o
ing. The complete set of EP lines was tested in parallel P
for effects on other signaling pathways, including the
growth promotion by dMyc, and the EP insertions in t
the Susi locus were not found in screens other than r
our dINR screen (data not shown; P. Gallant, personal c
communication). S
t
pSusi Overexpression Reduces Growth
To further investigate the possibility that Susi is an in- f
Shibitor of PI3K/PKB signaling, we compared the pheno-
type of Susi-overexpressing flies with chico mutant t
iflies, in which the activity of PI3K/PKB signaling is im-
paired (Bohni et al., 1999). Chico is the Drosophila or-
ftholog of IRS1-4, and chico flies are small because of
a cell-autonomous reduction in the rate of cell prolifera- t
ation and cell growth. Ubiquitous overexpression of Susi
throughout development resulted in flies that were re- ouced in size (Figures 1E and 1F). Overexpression of
usi in the developing eye resulted in smaller eyes with
ewer ommatidia (Figures 1G–1I). Susi overexpression
lso reduced photoreceptor cell size in a cell-autono-
ous manner (Figure 1J). As for the eyes, wings over-
xpressing Susi during development were smaller due
o a reduction in cell number (−41%) and cell size
−27%) (Figures 1K and 1L and data not shown). Over-
xpression of the apoptosis inhibitor P35 (Hay et al.,
994) together with Susi in the developing eye or wing
id not suppress the growth-inhibition phenotypes, in-
icating that Susi does not attenuate growth by in-
reasing apoptosis. In all these experiments, Susi over-
xpression reduced growth but did not affect cell
pecification or patterning.
To further analyze the effect of Susi overexpression
n cell division, we examined the growth capacity of
usi-overexpressing clones in the wing imaginal disc.
e found that Susi-overexpressing clones were smaller
han control clones because they contained fewer cells
hereas cell size was not changed (Figures 1M–1O).
hus, Susi-overexpressing cells divided at a lower rate
han control cells. Whereas cell-doubling time was 11.5
r (±0.48 hr, n = 10 clones) in control clones, it was
ignificantly increased to 14.1 hr (±1.65 hr, n = 11
lones) in Susi-overexpression clones (one-tailed t test:
< 0.025).
Apart from the growth phenotype, animals ubiqui-
ously overexpressing Susi were developmentally de-
ayed and resistant to starvation (see Supplemental Fig-
res S1A and S1B available with this article online). The
ffects of Susi overexpression on cell growth, cell pro-
iferation, developmental timing, and starvation resis-
ance are very similar to the Chico phenotype (Bohni et
l., 1999; Oldham et al., 2002), further supporting the
ypothesis that Susi is a negative regulator of PI3K/
KB signaling.
oss of Susi Function Increases Growth
verexpression phenotypes may be caused by ectopic
r increased gene activation and may thus not reflect
he physiological function of the gene. Therefore, it was
mportant to investigate the consequences of the loss
f Susi function. We identified loss-of-function alleles
n Susi by screening for chemically induced reversion
f the Susi gain-of-function phenotype (Experimental
rocedures).
Sequencing of the revertants revealed that two mu-
ant alleles introduced stop codons within the open
eading frame, thus resulting in the formation of trun-
ated proteins (Figure 2B). In contrast to the wild-type
usi protein, overexpression of these truncated pro-
eins in the developing eye did not cause a detectable
henotype, suggesting that the isolated Susi loss-of-
unction alleles are functional nulls (data not shown).
usi8 is a P element insertion in the locus and appears
o be a hypomorphic allele (see below, Figure 2A, and
n Experimental Procedures).
All heteroallelic combinations of Susi resulted in adult
lies with reduced viability and increased body size (de-
ected by increased weight and wing size; Figures 2C
nd 2D and data not shown). The developmental timing
f these flies was not altered. The same was observed
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(A–C) Susi was identified in a screen for negative regulators of PI3K/PKB signaling (A). Expression of dINR and a random gene X (achieved
by the insertion of an EP element) was activated by Gal4 specifically in the eye of Drosophila. Genes capable of suppressing the dINR
overexpression phenotype were selected. Overexpression of dINR in the eye of Drosophila causes massive overgrowth as compared to a
control eye (B and C).
(D) Cooverexpression of Susi (=EP7-66) suppresses the overgrowth phenotype of dINR.
(E and F) Ubiquitous overexpression of Susi reduces body size.
(G and H) Eye-specific overexpression of Susi during development results in small eyes that consist of fewer ommatidia.
(I) Histological section through an eye of the same genotype as shown in (H) reveals normal differentiation and patterning.
(J) Overexpression of Susi in clones in the developing eye reduces cell size but does not affect cell differentiation or patterning. The tissue
overexpressing Susi is labeled by the absence of the white marker and therefore lacks the red pigmentation. The border of the clone is
indicated by a white line.
(K and L) Overexpression of Susi in the developing wing reduces wing size without affecting patterning.
(M–O) Overexpression of Susi in clones in the developing wing disc reduces cell proliferation but not cell size. The clones are marked by
expression of the GFP marker. The differences in cell number and clone area are significant (one-tailed t test, p < 0.025; n = 10 for control
clones, n = 11 for Susi-overexpressing clones, error bars indicate SD).
Genotypes (all flies are females): (B) y w; GMR-Gal4 UAS-dINR/+, (C) y w; GMR-Gal4/+, (D) y w; EP(7-66)/GMR-Gal4 UAS-dINR, (E) y w; da-
Gal4/+, (F) y w/y w UAS-Susi-HA; da-Gal4/+, (G) y w; ey-Gal4/+, (H and I) y w; ey-Gal4/UAS-Susi-HA, (J) y w hs-Flp/y w; GMR>w+>Gal4/+;
UAS-Susi/+, (K) y w MS1096-Gal4/y w, (L) y w MS1096-Gal4/y w; UAS-Susi-HA/+, (M) y w hs-Flp/y w; Act>CD2>Gal4 UAS-GFPnls/+, (N) y w
hs-Flp/y w; Act>CD2>Gal4 UAS-GFPnls/UAS-Susi-HA.for Susi alleles over a deficiency uncovering the locus
(Df(2L)b87e25). The increase in body weight was 27%
when Susi1/Susi2 flies were compared with EP(7-66)/
Susi2 control flies.
The body size phenotype of Susi flies was weakerthan that observed for flies homozygous for a hypomor-
phic allele of dPTEN (Oldham et al., 2002). In addition,
metabolic parameters like lipid and glycogen content
that are changed in dPTEN mutants (Oldham et al.,
2002) were normal in Susi mutants (Supplemental Fig-
Developmental Cell
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(A) Genomic organization of the Susi locus. The insertion sites of three P elements that are putative alleles of Susi are indicated.
(B) Molecular characterization of two Susi loss-of-function alleles. Arrows indicate the starting points of the truncations. Mutant alleles are
Susi1, CAG (Q649)/ TAG (stop), and Susi4, CAG (Q155)/ TAG (stop). The position of the predicted coiled-coil domain (amino acids 916–
942) is also shown. Error bars indicate SD.
(C) Flies lacking Susi function display an increased body weight as compared to heterozygous Susi2/+ or Susi2/EP(7-66) flies (p < 0.001, n =
20 for each genotype).
(D) Wing size is increased in Susi1/Susi2 mutants (p < 0.025, n = 9 per genotype).
(E) The size reduction of chico1 flies is partially rescued in chico1, Susi1 double mutants. A similar though weaker effect is seen in chico1,
Susi8 flies, indicating that Susi8 represents a hypomorphic allele.
(F) Susi1 partially rescues the reduced number of ommatidia in chico1 eyes.
(G) Size comparison of chico1 mutant, chico1, Susi1 double mutant, and chico1, Susi1/CyO control flies.
Genotypes are as indicated. All flies are females. For (F), genotypes are: “control:” y w ey-Flp/y w; FRT40/cl2L3 w+ FRT40, “Susi:” y w ey-Flp/y
w; Susi1 FRT40/cl2L3 w+ FRT40, “chico1:” y w ey-Flp/y w; chico1 FRT40/cl2L3 w+ FRT40, “chico1 Susi:” y w ey-Flp/y w; chico1 Susi1 FRT40/
cl2L3 w+ FRT40.ure S2), indicating that Susi is less limiting for growth g
aand metabolism than dPTEN. We wondered whether
Susi function becomes more limiting in a chico mutant cenetic background, in which PI3K/PKB signaling is
bnormally low (Bohni et al., 1999). Flies mutant for
hico are small because they contain fewer and smaller
Susi Inhibits PI3K/PKB Signaling
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were significantly larger than chico flies but still smaller
than control flies (Figures 2E and 2G). The relative in-
crease in body weight caused by removal of Susi func-
tion was stronger in a chico1 genetic background than
in a wild-type background (Figures 2C and 2E). In ex-
periments including Susi1, this increase was 27% in a
wild-type background and 88% in a chico1 back-
ground. Similarly, loss of Susi function partially sup-
pressed the reduction in ommatidial number of chico
flies (Figure 2F). Similar results were obtained with
other independent alleles of Susi and chico (data not
shown). Furthermore, Susi also suppressed the re-
duced body size of mutants in which the function of
dINR or dPKB was reduced (the hypomorphic alleles
dINR19 and dPKB3, data not shown).
Conversely, loss of Susi enhanced the phenotype of
weak dPTEN mutant alleles. Flies homozygous for the
hypomorphic dPTEN2L100 allele are viable and in-
creased in size (Oldham et al., 2002). Susi, dPTEN2L100
flies displayed synthetic lethality. Flies in which the
function of both Susi and dPTEN was impaired by a
tissue-specific recombination system (Newsome et al.,
2000) showed a strong enhancement of the big eye
phenotype of dPTEN2L100. This size increase was at
least in part due to an increase in the number of omma-
tidia (data not shown). Thus, Susi shows strong genetic
interactions with PI3K/PKB signaling components, and
the loss-of-function phenotype of Susi is complemen-
tary to its gain-of-function phenotype. This indicates
that the Susi gain-of-function phenotype reflects the
overactivation of the natural function of Susi and that
Susi is a negative regulator of PI3K/PKB signaling.
Susi Inhibits PI3K/PKB Signaling Downstream
of dINR but Upstream of dPI3K
We chose three different approaches to address whether
Susi indeed inhibits PI3K/PKB signaling and to estab-
lish at which level of the cascade Susi acts. First, we
tested the effect of Susi overexpression on the expres-
sion of a target gene of PI3K/PKB signaling. Second,
we tested whether overexpression of Susi reduced the
levels of PIP3, a key component of the PI3K/PKB sig-
naling cascade. Finally, we checked whether Susi could
suppress phenotypes caused by constitutive activation
of components of PI3K/PKB signaling.
The transcription factor dFOXO is negatively regu-
lated by PI3K/PKB signaling (Junger et al., 2003).
dFOXO activates the transcription of d4EBP, and a lacZ
reporter line for d4EBP has been used as readout for
dFOXO activity (Junger et al., 2003; Puig et al., 2003).
In a wild-type background, overexpression of dFOXO
in the developing eye is not sufficient to induce expres-
sion of the d4EBP reporter, presumably because insulin
signaling and specifically dPKB activity is high enough
to phosphorylate and inactivate dFOXO protein (Figure
3A). However, when dPKB activity is reduced by co-
overexpression of dPTEN or dominant-negative dPI3K,
dFOXO expression results in a robust activation of the
d4EBP reporter (Figure 3B; Junger et al., 2003). If Susi
directly inhibits PI3K/PKB signaling, it should release
dFOXO inhibition in a manner similar to dPTEN. Indeed,
cooverexpression of Susi and dFOXO induced d4EBPFigure 3. Susi Overexpression Allows dFOXO to Activate Target
Gene Expression
(A) dFOXO overexpression in the eye imaginal disc posterior to the
morphogenetic furrow does not induce expression of the d4EBP-
lacZ reporter (Thor1). The EP insertion EP(35-147) (Junger et al.,
2003) was used to activate dFOXO expression.
(B) Reducing PI3K/PKB signaling by cooverexpression of dPTEN
enables dFOXO to induce d4EBP-lacZ.
(C) Susi overexpression does not result in an induction of d4EBP-
lacZ.
(D) Cooverexpression of dFOXO and Susi, however, suffices to in-
duce d4EBP-lacZ.
Genotypes are: (A) GMR-Gal4/Thor1; EP(35-147)/+, (B) GMR-Gal4
UAS-dPTEN/Thor1; EP(35-147)/+, (C) GMR-Gal4 UAS-Susi/Thor1,
(D) GMR-Gal4 UAS-Susi/Thor1; EP(35-147)/+.reporter expression, indicating that Susi overexpres-
sion attenuates dPKB activity (Figure 3D). Overexpres-
sion of Susi or dPTEN alone, however, was not suffi-
cient to induce the d4EBP reporter (Figure 3C and data
not shown). These results suggest that growth suppres-
sion by Susi overexpression involves the dephosphory-
lation and nuclear translocation of dFOXO.
To test whether Susi is suppressing PI3K/PKB signal-
ing by reducing PIP3 levels, we made use of a GFP-
PH domain fusion protein (tGPH) that specifically binds
PIP3 and therefore serves as a reporter for PIP3 levels
in vivo (Britton et al., 2002). The amount of membrane
bound tGPH reflects PI3K/PKB signaling activity. In the
eye imaginal disc of control flies, tGPH was recruited
to the membrane in proliferating cells but was not de-
tectable in differentiating cells posterior to the morpho-
genetic furrow (Figure 4A), suggesting that PI3K/PKB
signaling is low in differentiating cells. Overexpression
of dINR posterior to the morphogenetic furrow resulted
in a severe increase of PIP3 levels at the membrane as
detected by the tGPH reporter (Figure 4B). Cooverex-
pression of dPTEN significantly reduced PIP3 levels
(Figure 4C). Cooverexpression of Susi together with
dINR reduced PIP3 levels to a similar extent (Figure 4D).
This result confirms that Susi inhibits PI3K/PKB signal-
ing upstream of PIP3. The reduced PIP3 levels are not
caused by a reduction in the amount of dINR at the
membrane, since immunofluorescent detection of dINR
showed only a very subtle reduction in protein levels
(Figures 4B# and 4D#).
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Upstream of PI3K
The localization of tGPH (green signal in
[A]–[G]) is shown in eye imaginal discs. In-
sets show higher magnification of single om-
matidial clusters from the posterior part. Ex-
pression of dINR is shown in red in (A#)–(D#),
and nuclear DNA staining (DAPI) is shown in
blue in (A#)–(G#).
(A) In wild-type eye imaginal discs, the tGPH
reporter is not recruited to the membrane,
indicating that PI3K signaling activity is low.
(B) Overexpression of dINR posterior to the
furrow causes a strong relocation of tGPH to
the membrane.
(C) Cooverexpression of dPTEN together
with dINR reduces this membrane signal
partially.
(D) The same is observed when Susi is co-
overexpressed with dINR. Cooverexpression
of dPTEN or Susi reduces dINR protein
levels only slightly (B#–D#).
(E) Overexpression of dPI3K-CAAX results in
a strong tGPH signal at the membrane.
(F and G) While cooverexpression of dPTEN
suppresses this signal at the membrane (F),
Susi cooverexpression does not exert a sup-
pressive effect (G). The region posterior to
the morphogenetic furrow is indicated by a
bar below (G).
Genotypes are: (A, A#) y w; tGPH/+, (B, B#) y
w; UAS-dINR tGPH/+; GMR-Gal4/+, (C, C#) y
w; UAS-dINR tGPH/+; GMR-Gal4/UAS-
dPTEN, (D, D#) y w; UAS-dINR tGPH/+;
GMR-Gal4/UAS-Susi, (E, E#) UAS-PI3K-
CAAX tGPH/+; GMR-Gal4/+, (F, F#) GMR-
Gal4 UAS-dPTEN/UAS-PI3K-CAAX tGPH,
(G, G#) UAS-PI3K-CAAX tGPH/+; UAS-Susi-
HA/GMR-Gal4.To further refine the placement of Susi within the d
pPI3K/PKB signaling cascade, we induced eye over-
growth phenotypes by expressing constitutively active S
dversions of dINR, dPI3K, and dPKB (Leevers et al.,
1996; Stocker et al., 2002) and asked which of these s
Tphenotypes could be suppressed by Susi overexpres-
sion. dINRact is a truncated version of dINR lacking the m
oligand binding domain that is sufficient to trigger li-
gand-independent receptor autophosphorylation (see
pExperimental Procedures and Supplemental Figure S1).
As constitutively active versions of dPI3K and dPKB, m
dwe used the membrane-targeted dP110-CAAX and
myr-dPKB, respectively (Leevers et al., 1996; Stocker e
pet al., 2002). As a control for the epistasis tests, we
used dPTEN. Consistent with its function as a PIP3-3# o
aphosphatase, cooverexpression of dPTEN strongly
suppressed the phenotypes caused by dINRact and a
ddP110-CAAX but not myr-dPKB overexpression (Figure
5I and data not shown). Susi overexpression com- t
rpletely suppressed the phenotypes resulting from over-
expression of dINRact (Figure 5D). In contrast, the dP110-CAAX or myr-dPKB phenotypes were sup-
ressed only weakly (Figures 5F and 5H). The fact that
usi is genetically epistatic over dINR but not over
PI3K and dPKB indicates that Susi inhibits dPI3K/PKB
ignaling downstream of dINR but upstream of dPI3K.
he weak suppression of dPI3K-CAAX and myr-dPKB
ay be explained by the effect of increased Susi levels
n the activity of the endogenous dPI3K and dPKB.
Overexpression of constitutively active dPI3K-CAAX
osterior to the furrow increased PIP3 levels at the
embrane to a similar extent as dINR overexpression
id (Figure 4E). If Susi acts upstream of dPI3K, Susi
xpression should not alter PIP3 levels in flies that ex-
ress dPI3K-CAAX. Indeed, whereas cooverexpression
f dPTEN suppressed the increase in PIP3 caused by
n activation of dPI3K, Susi did not do so (Figures 4F
nd 4G). The effects of Susi on the expression of a
FOXO target gene and on PIP3 levels together with
he results of the epistasis analysis indicate that Susi
egulates growth by inhibiting PI3K/PKB signaling
ownstream of dINR and upstream of dPI3K.
Susi Inhibits PI3K/PKB Signaling
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(A and B) Overexpression of UAS-Susi under control of GMR-Gal4
results in a slight reduction of eye size (B) as compared to a control
eye (A).
(C, D, and J) The hyperplastic eye phenotype caused by overex-
pression of UAS-dINRact under control of GMR-Gal4 (C) is sup-
pressed by cooverexpression of UAS-Susi (D) but not by reducing
the levels of Dilp1-5 (J). Df(3L)AC1 uncovers the transcription units
of Dilp1-5 (Brogiolo et al., 2001).
(E–H) In contrast, the overgrowth phenotypes caused by dP110-
CAAX (E) or by myr-dPKB (G) are not suppressed by cooverexpres-
sion of Susi (F and H).
(I) The dP110-CAAX phenotype is readily suppressed by cooverex-
pression of dPTEN.
Scale bar in (A) represents 200 m.
Female flies of the following genotypes are shown: (A) y w; GMR-
Gal4/+, (B) y w; GMR-Gal4 UAS-Susi/+, (C) y w; GMR-Gal4 UAS-To test whether Susi inhibits dPI3K function by direct
dINRact/+, (D) y w; GMR-Gal4 UAS-dINRact/+; UAS-Susi/+, (E) y w;
GMR-Gal4 UAS-dP110-CAAX/+, (F) y w; GMR-Gal4 UAS-dP110-
CAAX/+; UAS-Susi/+, (G) y w; GMR-Gal4/+; UAS-myr-dPKB/+, (H) y
w; GMR-Gal4/UAS-Susi; UAS-myr-dPKB/+, (I) y w; GMR-Gal4 UAS-
dP110-CAAX/+; UAS-dPTEN/+, (J) y w; GMR-Gal4 UAS-dINRact/+;
Df(3L)AC1/+.Susi Is Localized at the Plasma Membrane and
Binds the Regulatory Subunit of PI3K In Vitro
PI3K/PKB signaling between dINR and dPI3K most
likely occurs at the plasma membrane (Lizcano and
Alessi, 2002). If Susi acts directly to inhibit signaling
between these components, it should be localized at
the membrane. Alternatively, Susi could bind and titrate
dP60 in the cytoplasm. A Susi variant containing a
C-terminal hemaglutinin (HA) tag (Susi-HA, see Experi-
mental Procedures) was localized at specific regions of
the plasma membrane in the large cells of the fat body
(Figures 6A and 6A#). In eye and wing imaginal discs,
Susi-HA was localized at the plasma membrane and
in the cytoplasm and was excluded from the nucleus
(Figures 6B and 6B#). Thus, the localization of Susi at
the plasma membrane and in the cytoplasm is consis-
tent with its proposed activity between dINR and
dPI3K.Figure 6. Susi Is Localized in the Cytoplasm and at the Plasma
Membrane
(A) Expression of Susi fused to an HA-tag (Susi-HA) in clones in the
fat body. Susi-HA is localized to part of the plasma membrane (red).
Clones are marked by the expression of GFP (green). (A#) Same
picture as in (A) but without showing GFP.
(B) Expression of Susi-HA in the wing imaginal disc. Susi is local-
ized to the cytoplasm and to the plasma membrane (red). Nuclei
are stained with DAPI (blue). (B#) Same picture as in (B) but without
the staining of the nuclei.
Genotypes are: (A, A#) y w hs-Flp/y w; Act>CD2>Gal4 UAS-GFPnls/+;
UAS-Susi-HA/+, (B, B#) y w UAS-Susi-HA/y w; Act5c-Gal4/+.
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iand dP60 by GST-mediated precipitation after transfec-
tion into HEK293 cells. Indeed, a GST-dP60 fusion pro- d
otein was able to precipitate HA-tagged Susi (Figure 7A).
GST-Susi also precipitated HA-dP60 when the tags
qwere switched (Figure 7B). In contrast to GST-dP60,
however, GST-Susi did not bind to myc-dP110 (Figure t
m7C). To test whether Susi inhibits PI3K function by com-
peting with the dP110 catalytic subunit for binding to c
(dP60, we performed competition assays. GST-dP60 ef-
ficiently precipitated myc-dP110 irrespective of the r
apresence of increasing amounts of Susi-HA. Similarly,
GST-dP60 precipitated HA-Susi even in the presence of r
nincreasing amounts of myc-dP110 (Figure 7D). Taken
together, these results indicate that Susi interacts with n
dP60 but not with dP110 and that this interaction is not
altered by the binding of dP60 to dP110. S
T
aDiscussion
s
SSusi, a Negative Regulator of Growth
We have identified Susi in a misexpression screen for t
Sgenes suppressing growth induced by overexpression
of dINR in the Drosophila eye. Several lines of evidence r
bsuggest that Susi is a novel negative regulator in insulin
signaling that acts between dINR and dPI3K. (1) Gain
sand loss of Susi function mimic the loss-of-function
phenotypes of positive and negative regulators of the d
rinsulin pathway, respectively. Susi regulates cell growth
by controlling cell number and cell size, but does not t
daffect programmed cell death. (2) Susi, like dPTEN, re-
leases PKB-dependent inhibition of dFOXO, thus ena- r
bling the expression of the dFOXO target gene d4EBP.Figure 7. Susi Binds dP60 but Not dP110
(A–C) GST pull-down assays.
(A) HA-tagged Susi together with dP60 fused to GST or GST alone as negative control were transiently transfected into HEK293 cells. Cell
lysates were used in a GST pull-down assay, and isolated proteins were analyzed by Western blot using α-HA antibodies. The data of two
independent experiments (exp 1 and exp 2) are shown.
(B) GST pull-down assay like in (A) except that the GST and HA tags on Susi and dP60 have been reversed.
(C) GST pull-down assays to test binding of GST-tagged Susi to dP110 fused to a Myc-tag. Myc-dP110 does not bind to GST-Susi-HA.
However, it binds GST-P60 in a parallel experiment as indicated in a Western blot using a α-Myc antibody.
(D) Competition experiment for dP60 binding of dP110 and Susi. Varying amounts of Susi-HA and Myc-dP110 were expressed as indicated
(see lysate panels), before GST-dP60-associated proteins were precipitated (GST pull-down).
For all experiments, total expression levels of the transfected proteins were also analyzed by Western blot using α-HA, α-GST, or α-Myc
antibodies (indicated as “cell lysates” in [A]–[D]).3) Susi, like dPTEN, attenuates PIP3 levels induced by
ncreased dINR activity, but, unlike dPTEN, fails to re-
uce PIP3 levels induced by a membrane-tethered form
f dPI3K.
Although complete loss of Susi function results in
ualitatively similar phenotypes as loss of dPTEN func-
ion, the phenotypes are generally weaker. Whereas ho-
ozygous Susi flies are viable and increased in size,
omplete loss of dPTEN function results in lethality
Gao et al., 2000; Goberdhan et al., 1999). Consistently,
emoval of dPTEN function using the ey-FLP system
lso resulted in a stronger increase in head size than
emoval of Susi function (data not shown). Thus, the
egative regulatory function of Susi on PI3K/PKB sig-
aling is less pronounced than that of dPTEN.
usi Binds to the Regulatory Subunit of dPI3K
he genetic analysis presented here indicates that Susi
cts between dINR and dPI3K, making dPI3K a pos-
ible target for Susi function. The protein sequence of
usi includes a putative coiled-coil (CC) protein interac-
ion domain. We show by in vitro binding studies that
usi binds to the regulatory subunit dP60 of dPI3K. This
esult suggests that Susi inhibits PI3K/PKB signaling
y binding and thereby inhibiting PI3K.
How does binding of Susi to dPI3K inhibit PI3K/PKB
ignaling? Susi may cause the degradation of dP60 and
P110. Alternatively, Susi may interfere with any step
equired for the activation of dPI3K, such as the forma-
ion of the dP60/dP110 heterodimer, recruitment of
PI3K to the membrane, or the conformational changes
equired for the activation of dPI3K.
Overexpression of Susi in flies does not reduce
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825dP110 protein levels and does not suppress the dP60
overexpression phenotype (data not shown), making it
unlikely that Susi causes the degradation of either
dP110 or dP60.
Cooverexpression of Susi with dP110 and dP60 in a
cell culture system does not interfere with the formation
of the dP110/P60 heterodimer. Therefore, it is unlikely
that Susi interferes with the assembly of the dPI3K ho-
loenzyme. In fact, we showed that binding of Susi to
dP60 is independent of the binding of dP60 to the
dP110 catalytic subunit. Since Susi regulates the activ-
ity of the wild-type but not of the membrane-tethered
form of dPI3K, it may regulate the membrane recruit-
ment and/or activation of dPI3K. Upon overexpression,
a significant fraction of Susi protein is located at the
membrane. It is therefore unlikely that Susi functions
by retaining the dP60/dP110 complex in the cytoplasm.
Since our binding studies suggest that Susi forms a
trimolecular complex with dP60 and dP110, it is pos-
sible that Susi interferes with PI3K activity by suppress-
ing a conformational change required for dPI3K acti-
vation.
Is Susi Function Conserved in Mammals?
Based on sequence comparison, we have not been
able to identify a clear ortholog of Susi outside insect
species. Furthermore, Susi is unable to negatively regu-
late insulin signaling in mammalian cells. Under condi-
tions where GST-Susi interacts with dP60, no interac-
tion with the mammalian homologs of dP60, P85α and
P85β, could be observed. Moreover, overexpression of
Susi in COS-7 cells was unable to counteract the in-
creased phospho-PKB levels caused by the overex-
pression of the human insulin receptor (data not
shown). The only domain recognizable in Susi is the CC
domain, which is involved in protein-protein interac-
tions and is present in a large number of different pro-
teins. Interestingly, the domain is also present in an-
other negative regulator of PI3K activity, the regulator
of ubiquitous kinase (Ruk) protein. Ruk, also known as
CIN85 or SETA, is an adaptor-type protein belonging to
the CD2AP/CMS family and exists in three isoforms
(Gout et al., 2000; Verdier et al., 2002). RukL consists of
three SH3 domains, a proline-rich domain, and a
C-terminal CC domain. Its interaction with the P85 sub-
unit of PI3K requires the proline-rich domain of RukL
and the SH3 domain of P85. The role of the C-terminal
CC domain has not been tested. Susi lacks SH3 and
proline-rich domains. Thus, Susi and RukL appear to
interact in different ways with the corresponding PI3K
adaptors dP60 and P85, respectively. Susi may there-
fore define a novel, possibly insect-specific, type of
negative regulation of PI3K activity.
Susi May Attenuate Insulin Signaling
in a Circadian Rhythm
The relatively weak Susi loss-of-function phenotype
suggests that Susi is involved in fine-tuning the cellular
response to insulin. Interestingly, Susi expression in
adult flies is modulated in a circadian rhythm. Accord-
ing to three independent studies, expression levels of
Susi are higher during the night than during the day,
reaching a maximum during the second part of thenight (Claridge-Chang et al., 2001; McDonald and Ros-
bash, 2001; Ueda et al., 2002). In mammals, insulin sen-
sitivity shows diurnal changes. In humans and rats, in-
sulin sensitivity increases toward the onset of the
activity period (day for humans and night for rats) (la
Fleur et al., 2001; Schulz et al., 1983). The mechanisms
underlying this phenomenon are unknown. Insulin regu-
lates carbohydrate metabolism in adult flies in a similar
way as in mammals (Rulifson et al., 2002), and flies
show a sleep-like behavior during the night (Hendricks
et al., 2000; Shaw et al., 2000). Susi may cause diurnal
changes of insulin sensitivity in Drosophila similar to
those in mammals. High levels of Susi during the night
may contribute to a reduction in cell growth and metab-
olism in anticipation of the lack of feeding during this
time. It should be pointed out, however, that the circa-
dian expression of Susi has been described in adult
flies. We have characterized the role of Susi in larval
growth regulation. The fact that Susi mutant flies are
viable provides an ideal basis for addressing the poten-
tial role of Susi in circadian regulation of metabolism
and physiology in the adult.
Experimental Procedures
Fly Work
All experiments were done in a y w genetic background unless
otherwise indicated. The following published fly stocks were used:
da-Gal4 (Wodarz et al., 1995), Df(3L)AC1 (Brogiolo et al., 2001),
dINRE19 (Brogiolo et al., 2001), dPKB3 (Stocker et al., 2002), EP(35-
147) (Junger et al., 2003), ey-Flp; cl2L3 w+ FRT40 (Newsome et al.,
2000), ey-Gal4 (Halder et al., 1998), GMR-Gal4 (Hay et al., 1994), hs-
Flp122; Act>CD2>Gal4 UAS-GFPnls (Neufeld et al., 1998), hs-Flp122;
GMR>w+>Gal4 (Brogiolo et al., 2001), tGPH (Britton et al., 2002),
d4EBP-lacZ, also called Thor1 (Bernal and Kimbrell, 2000), UAS-
dINR (Brogiolo et al., 2001), UAS-dP110-CAAX (Leevers et al.,
1996), UAS-dPTEN (Huang et al., 1999), UAS-myr-dPKB (Stocker
et al., 2002), and UAS-Susi, also called UAS-B4 (Sotillos et al.,
1997). The stocks Df(2L)b87e25 and l(2)05337 were obtained from
the Bloomington Stock Center, and en-Gal4 flies were kindly pro-
vided by K. Basler. We used a novel insertion of GMR-Gal4 on the
third chromosome (called GMR-Gal4.3A), which was generated by
F. Rintelen by mobilizing the original GMR-Gal4 insertion.
Crosses were performed at 25°C except for crosses with dINRact
flies, which were performed at 18°C.
Generation of Susi-HA Flies
Genomic DNA of flies containing UAS-Susi (Sotillos et al., 1997)
was used as template in a PCR to amplify the Susi cDNA with the
oligonucleotides 5#-GCGGCCGCATGAACGAGACCTTAAAGCTG-3#
and 5#-GCGGCCGCAGTTTGAGCGTATTGTAAATGTTATC-3#. Sub-
sequently, the Susi cDNA was cloned upstream of the hemaglutinin
(HA) tag into the NotI site of the Drosophila transformation vector
pUAST-4HA to generate plasmid pFW40. This plasmid encodes a
modified version of Susi, which has a C-terminal HA-tag (Susi-HA).
The plasmid pUAST-4HA was provided by Isabel Hanson (MRC
Human Genetics Unit, Edinburgh, UK). It is a modified version of
pUAST (Brand and Perrimon, 1993), which was generated by clon-
ing four HA repeats into the XhoI site of pUAST (I. Hanson, personal
communication). Two fly strains containing independent insertions
of pFW40 were generated. For most experiments, we used the in-
sertion 40-1x on the third chromosome. Only for the experiment
where we overexpressed Susi-HA ubiquitously did we use the in-
sertion 40-117 because ubiquitous expression using insertion 40-
1x was lethal.
Identification of Susi
The EP screen in which we identified Susi will be described in detail
elsewhere (W.B., H.S., D. Nellen, K. Basler, and E.H., unpublished
data). Briefly, several EP insertions including EP(7-66) were isolated
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pdINR in the eye when cooverexpressed using the driver GMR-Gal4.
Plasmid rescue of EP(7-66) revealed that this EP element was in-
serted 279 bp upstream of the predicted ATG of Susi (coding se- S
quence as defined by CG9239-RB_CDS, Berkeley Drosophila Ge- S
nome Project). t
t
1Isolation of Susi Alleles
tWe performed a mutagenesis screen in which we selected mutated
cchromosomes carrying EP(7-66) that were no longer able to sup-
1press the dINR overexpression phenotype in the eye. For this pur-
pose, EP(7-66) males were fed 27 mM EMS (ethylmethanesulfo-
inate) (Lewis and Bacher, 1968) and subsequently crossed to GMR-
0Gal4 UAS-dINR virgins. 7500 F1 flies were screened for a reversion
tof the suppressive effect of EP(7-66) on the growth phenotype
scaused by GMR-GAL4 UAS-dINR. 30 selected flies were subse-
cquently backcrossed to GMR-Gal4 UAS-dINR, and 7 showed germ-
mline transmission of the mutation. The molecular nature of the mu-
stations was determined by amplifying genomic DNA of mutant flies
pby PCR and sequencing the PCR products. We could identify mu-
stations disrupting the Susi open reading frame for alleles Susi1 and
wSusi4. For the other EMS alleles, the molecular nature is unknown.
(The l(2)05337 chromosome contains a P element insertion in the
Susi locus (which we named Susi8) and a lethal second hit. We
removed this second hit by meiotic recombination and obtained C
Susi8 flies that were homozygous viable. Susi8 is likely to be a hy- I
pomorphic Susi allele because the P element is inserted 69 bp up- G
stream of the ATG. e
g
NAnalysis of Susi Loss of Function and Gain of Function
NBody weight and wing size were analyzed as described (Bohni et
oal., 1999). To analyze the behavior of mutant cells in clones, alleles
(of Susi were recombined onto FRT chromosomes, and clones in
mthe eye imaginal disc were induced using the ey-FLP system (New-
some et al., 2000).
Chromosomes doubly mutant for chico and Susi were generated
Sby meiotic recombination. Several independent recombinants were
analyzed with similar results.
SOverexpression clones were generated by means of the “FLP-
aout” technique using the lines hs-Flp122; Act>CD2>Gal4 UAS-
fGFPnls (Neufeld et al., 1998) and hs-Flp122; GMR>w+>Gal4 (Brogi-
olo et al., 2001), respectively. FLP-out clones were induced in lar-
vae either 56–80 hr after egg laying by a 14 min heat shock at 34°C A
(Act>CD2>Gal4) and analyzed 40 hr after induction, or 24–48 hr
after egg laying by a 1 hr heat shock at 37°C (GMR>w+>Gal4). W
g
JImmunohistochemistry and Histology
EAntibody staining was done using a mouse anti-HA antibody
T(1:1500, Roche) and an antibody against the C terminus of dINR
B(αINRct, 1:10,000) (Fernandez et al., 1995). Secondary antibodies
twere anti-rabbit TRITC (1:200) and anti-mouse FITC (1:500). Nuclei
gwere stained with DAPI. Pictures were taken using a Leica SP2
Kconfocal laser scanning microscope. To detect β-galactosidase ac-
Stivity, third instar larval discs were fixed and subjected to a stan-
dard X-gal color reaction for 16 hr at 37°C. Histological sections of
adult eyes were done as described (Basler and Hafen, 1988). R
R
dINRact Flies A
dINRact was designed similarly to a modified version of mammalian P
dINR that has been shown to be constitutively active (Lebwohl et
al., 1991). The minigene of dINRwt (Brogiolo et al., 2001) was di- R
gested using Eco47III and Csp451 and subsequently blunt-end li-
gated to remove the 5# part of the dINR cDNA encoding the extra- B
cellular domain (from amino acid 309 to 1110). This minigene, b
which encodes a truncated version of dINR missing the ligand m
binding domain, was cloned into the pUAST vector, and the result-
B
ing construct was used to generate transgenic flies. We confirmed
J
that dINRact is constitutively active by a biochemical approach
m
(Supplemental Figure S1) and by the following genetic experiment.
BThe deficiency Df(3L)AC1 uncovers the cluster encoding five of the
iseven putative dINR ligands, Drosophila insulin-like peptides
i(DILPs) 1–5 (Brogiolo et al., 2001). Reducing the levels of DILP 1–5
by 50% by this deficiency suppresses the overexpression pheno- Bype of wild-type dINR (Brogiolo et al., 2001), but it does not sup-
ress the overexpression phenotype of dINRact (Figure 5J).
2 Cell Lines and Transfection Assays with dINRact
2 cells were cultured as described (Fernandez et al., 1995). For
ransfection assays, we cloned the dINRact encoding sequence into
he EcoRI site of the pRmHa3 expression vector (Bunch et al.,
988). This construct was transiently transfected into S2 cells using
he N,N-bis(2-hydroxyethyl)-2 aminoethane sulfonic acid (Bes)/
alcium phosphate coprecipitate method (Bunch and Brower,
992).
For induction of dINRact expression, overexpressing cells were
ncubated in Schneider medium containing 0.1% calf serum and
.7 mM CuSO4 for 30 hr. After induction, cells were washed three
imes in PBS, resuspended in M3 medium containing 0.1% calf
erum, and left untreated (quiescent) or stimulated with insulin (re-
ombinant porcine insulin). After insulin treatment, cells were im-
ediately placed on ice and washed twice in ice-cold PBS. The
ubsequent cell extraction and analysis of cell extracts or immuno-
recipitates by SDS-PAGE and immunoblotting were done as de-
cribed (Fernandez et al., 1995). Antibodies used in this experiment
ere αINRct (Fernandez et al., 1995) and anti-phosphotyrosine
anti-pTyr) (Batzer et al., 1994).
ell Culture Experiments and Immunoprecipitation to Test
nteraction between Susi and dPI3K
ene constructs encoding the following fusion proteins were gen-
rated and cloned into the pcDNA3.1 expression vector (Invitro-
en): Susi with a C-terminal HA-tag and either with or without an
-terminal GST-tag, dP60 with either an HA-tag or a GST-tag at its
terminus, and dP110 with an N-terminal Myc-tag. Combinations
f these constructs were transfected into mammalian cells
HEK293). These cells were then used for GST pull-down experi-
ents (Pirola et al., 2001).
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rticle online at http://www.developmentalcell.com/cgi/content/
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